Euflexxa (English)

Euflexxa® is a hyaluronic acid-based viscosupplement designed for intra-articular injection in patients with osteoarthritis. By mimicking the natural synovial fluid, it enhances joint lubrication and cushioning, contributing to improved mobility and pain relief. This treatment is commonly used in individuals who have not achieved adequate symptom control with oral analgesics or physical therapy.

Formulated with a non-avian, bioengineered hyaluronic acid, Euflexxa® provides a well-tolerated and effective solution for osteoarthritis symptom relief. The treatment protocol consists of three weekly intra-articular injections, with each pre-filled syringe containing 2mL of hyaluronic acid (10mg/mL). Clinical studies indicate that its effects can last up to six months, making it a preferred option for long-term joint care before considering more invasive procedures.

Orthopedic specialists, rheumatologists, and other healthcare providers incorporate Euflexxa® into their treatment regimens to support joint function while reducing the need for oral pain management. Its high molecular weight formulation is designed to optimize joint biomechanics, offering patients a non-surgical approach to osteoarthritis management with minimal downtime. Proper administration ensures optimal efficacy and treatment outcomes.

Disclaimers:

– For professional use only. Must be administered by a licensed healthcare provider.

– Prescription required. Not intended for patient self-administration.

– Follow proper storage conditions to maintain product integrity.

– Use in accordance with local medical regulations and clinical guidelines.